Orange Biomed

Heading to #ADA2024? Come meet the Orange Biomed team, led by Forbes Korea’s 30 Under 30 feature, Yeaseul Park, Co-President of Orange Biomed. bit.ly/4ct5HQE Stop by poster 727-P, category 12-A, at the ADA's 84th Scientific Sessions (June 21-24, 2024 in Orlando, FL). Our team of experts will discuss how our new method of A1c testing can make diabetes care more accessible and affordable. #Diabetes #HealthCareNews #DiabetesNews #ADA #ScientificSessions #AmericanDiabetesAssociation #A1c #DiabetesCare #Endocrinology #DiabetesManagement #MedTechNews# #A1cTesting #ADA #MedTech #Forbes #ForbesKorea #Forbes30Under30 #diabetesinnovator

Check out #PharmNews’ recent article highlighting our new ISO 9001 certification for quality management systems: bit.ly/3WulOYi In the interview, Orange Biomed Co-President Yeaseul Park highlighted, “We are pleased to have been certified as having quality control capabilities that meet international standards through the acquisition of ISO 9001 certification. We are currently conducting clinical trials to prove clinical effectiveness and safety with the goal of obtaining FDA clearance.” Orange Biomed is presenting a poster presentation at the ADA's 84th Scientific Sessions (June 21-24, 2024 in Orlando, FL) to showcase the benefits of this new approach to A1c testing. If you're interested, stop by poster 727-P, category 12-A. #PharmaNews #Diabetes #HealthCareNews #DiabetesNews #ADA #ScientificSessions #AmericanDiabetesAssociation #A1c #DiabetesCare #Endocrinology #DiabetesManagement #MedTechNews #A1ctesting

Check out our interview with BioTimes to learn how our revolutionary new method of testing A1c is making diabetes management easier. https://bit.ly/4d2o5jk OBM rapid A1c resolves accuracy issues experienced with current POC A1c meters on the market that rely on protein quantification methods. By using advanced microfluidic technology, OBM rapid A1c can deliver the same level of accuracy as traditional laboratory equipment, all in a pocket-sized device. To learn more, please visit: https://bit.ly/40RW1tD Orange Biomed will be presenting a poster presentation at the ADA's 84th Scientific Sessions to showcase the benefits of this new approach to A1c testing. If you're interested, stop by poster 727-P, category 12-A. #Biotimes #Diabetes #HealthCareNews #DiabetesNews #ADA #ScientificSessions #AmericanDiabetesAssociation #A1c #DiabetesCare #Endocrinology #DiabetesManagement #MedTechNews

Attending the ADA's 84th Scientific Sessions? Stop by poster presentation 727-P, category 12-A to hear about our innovative new method of testing A1c. Learn more about our innovation in the meantime in our interview with MIT Technology Review: https://bit.ly/43LJg50 Missed ADA 2023? Check out our recap ahead of this year's conference: https://bit.ly/43Kokvg #ADA #AmericanDiabetesAssociation #ADAScientificSessions #ScientificSessions #ADA2024 #Diabetes #MITTechnologyReview #MITTechReview #MIT #A1c #diabetescare

As near the end of Women's History Month, we would like to honor female leaders who have made remarkable strides in diabetes treatment and care: https://bit.ly/4aoKe9r We extend our appreciation to Denise Faustman, Tracey D. Brown, Dana Lewis, Nicole Johnson, DrPH, and all women making a difference in the healthcare sector. Last year, Orange Biomed Co-Founder Yeaseul Park was the only woman featured in Forbes Korea's 30 Under 30 for Social Impact list. To learn more, please visit https://bit.ly/4ct5HQE #womenshistorymonth #womenshistory #femtech #womeninstem #stem #nationalwomenshistorymonth #internationalwomensday #femaleleaders #diabetes #diabetescare.

Did you know that 35% of kidney dialysis patients in the U.S. are Black, while only representing 13% of the total population? About 4.9M Black Americans age 20+ have diagnosed or undiagnosed diabetes. Read more about Black health equity challenges: https://bit.ly/3wkVvsS. Ensuring accurate early diagnosis of diabetes is critical to reducing complications like kidney failure. Read more about the risk factor minorities face to receive inaccurate A1C readings, a critical test in diagnosing diabetes: https://bit.ly/49GXMgL #a1c #diabetes #kidneydisease #patientnews #patients #medtech #medtechnews #healthequity #preventativecare #blackequity #bhm

1 in 3 Black Americans are projected to develop diabetes. As we end #BlackHistoryMonth, learn how the African American Diabetes Association is bridging health equity gaps for Black patients with diabetes: https://bit.ly/3T6dI6r Organizations such as the AADA offer educational resources, events, and projects to support Black communities disproportionately affected by diabetes. To learn more about AADA's current initiatives, visit: https://bit.ly/4bH6X26. #BlackHistoryMonth #AADA #AfricanAmericanDiabetesAssociation #BlackHistory #BHM #DiversityAndInclusion #Healthcare #HealthcareNews #Diversity #Inclusion #Diabetes

As Trulicity and Ozempic continue to gain popularity for weight loss, people with Type 2 diabetes face shortages to fill their critical prescriptions: https://bit.ly/49sZxh8 Kurt Reidel emphasizes the importance of Trulicity for his Type 2 diabetes by explaining, "It helps bring your sugar down and helps with your A1C. If you have a high A1C, you can cause damage to your heart." Facing over a month now without a refill, Reidel is taking extra precautions to monitor his diabetes, fearing hospitalization if his condition worsens. Dr. Bruce Y. Lee of CUNY Graduate School of Public Health and Health Policy warns the general public about the ripple effects of using GLP1 drugs for weight loss by stressing, "Please think of the diabetic who doesn't have it right now, or the kid that needs it that can't get it." #ozempic #trulicity #type2diabetes #diabetes #a1c #healthcarenews #health #diabetesawareness #bloodsugar #weightloss #diabetesmanagement #chronicillness

Orange Biomed is eager to attend the 84th Scientific Sessions hosted by the American Diabetes Association. Learn more about the 2024 Scientific Sessions here: bit.ly/3OckaFW Are you attending the sessions? If so, read our interview with MIT Technology Review to learn how Orange Biomed is leveraging microfluidic technology to advance diabetes treatment. bit.ly/3LO3tOY #a1c #a1ctest #diabetes #diabetescare #diabetesmanagement#healthcare #diabetesawareness #diabetesresearch #ADA2024 #AmericanDiabetesAssociation #2024ADAScientificSessions #ADA #ADAScientificSessions #MITTechnologyReview #MITTechReview #MIT

It's Glaucoma Awareness Month. Research has found that diabetes is associated with an increased risk of developing glaucoma. Some studies suggest that the risk may be twice as high. Learn more: bit.ly/48BKq4D #Glaucomaawarenessmonth #glaucoma #glaucomaawareness #openangleglaucoma #diabetescare #diabetesnews #healthcare #diabetesawareness #diabetesresearch #a1c #a1ctest #diabetestypeone #diabetestype2 #type1diabetes #type2diabetes